Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04371120 · ClinicalTrials.gov registry record
Brain Injury Self-Efficacy Scale Validation
A clinical trial, sponsored by Rehabilitation Hospital of Indiana.
- Terminated
- Registry status
- 150
- Enrollment target
NCT04371120: Clinical Trial study, sponsored by Rehabilitation Hospital of Indiana.
NCT04371120 is a clinical trial that was terminated before completion, run by Rehabilitation Hospital of Indiana. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04371120 was terminated before completion, sponsored by Rehabilitation Hospital of Indiana.
- TERMINATED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the Brain Injury Self-Efficacy Scale as a measure of self-efficacy in brain injury by comparing it with other measures of self-efficacy, the GSE, and PROMIS self-efficacy.
Primary Outcome
This measures assesses perceived self-efficacy (PSE) regarding a person's brain injury. The scale ranges from 0 (Not at all confident) to 4 (Extremely confident). This measure provides a total score in which higher scores mean greater self-efficacy.
Interventions
- DIAGNOSTIC_TEST BICS Q
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2023-06-30 |
Why NCT04371120 stopped before completion
NCT04371120 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which BICS Q is the first listed.
NCT04371120 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04371120 about?
NCT04371120 is a clinical study titled "Brain Injury Self-Efficacy Scale Validation". The purpose of this study is to validate the Brain Injury Self-Efficacy Scale as a measure of self-efficacy in brain injury by comparing it with other measures of self-efficacy, the GSE, and PROMIS self-efficacy.
What is the current status of trial NCT04371120?
This trial is currently terminated. The enrollment target is 150 participants. The study started on 2019-04-01. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT04371120?
The interventions under investigation include: BICS Q (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04371120?
This trial is sponsored by Rehabilitation Hospital of Indiana, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI